摘要
背景与目的:肝细胞癌(HCC)是世界范围内癌症死亡的第二大原因.。在患者的基因毒性应激性往往导致较差的临床结果,并深入Nrf2 /上调相关的信号通路。在这项研究中,我们研究了两种indazolo [3,2-b]喹唑啉酮的抗癌活性之间的联系(IQ)的衍生物,iq-7和iq-12,及其对Nrf2信号通路/效果。 方法:我们最初测定iq-7和iq-12 Hep3B细胞(肝癌细胞)和肝(正常人肝细胞)的细胞系,并进一步检测Nrf2 /影响信号通路与细胞凋亡。 结果:iq-7和iq-12下调Nrf2及其下游靶基因的表达水平,如NQO1、HO-1和GCLC。在iq-7或iq-12对Hep3B细胞,线粒体膜电位下降而促凋亡蛋白VDAC1表达水平与抗凋亡蛋白Bcl-2分别显着的增加和减少。此外,iq-7(但不iq-12)诱导caspase-3活性。有趣的是,iq-7出现选择性地抑制Hep3B细胞同时具有对HL-7702细胞罕见的不良影响。 结论:两种化合物诱导凋亡和抑制Nrf2/ARE信号通路在肝癌细胞,并iq-7提出对癌细胞的特异度。这些化合物的设计可能因此代表设计的喹唑啉衍生物可以选择性地针对癌细胞的新策略。
关键词: 喹唑啉,喹唑啉酮,肝细胞癌,基因,细胞凋亡。
Current Molecular Medicine
Title:Indazolo[3,2-b]quinazolinones Attack Hepatocellular Carcinoma Hep3B Cells by Inducing Mitochondrial-Dependent Apoptosis and Inhibition of Nrf2/ARE Signaling Pathway
Volume: 16 Issue: 9
Author(s): Y. Zhang, R. Qiao, D. He, Z. Zhao, S. Yang, H. Zou, X. Zhang, M. Wu, J. Chen, P. Chen
Affiliation:
关键词: 喹唑啉,喹唑啉酮,肝细胞癌,基因,细胞凋亡。
摘要: Background and Objective: Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. Genotoxic stress resistance in patients often contributes to poor clinical outcomes, and is intensively associated to the upregulation of Nrf2/ARE signaling pathway. In this study, we examined the connection between the anticancer activity of two novel indazolo[3,2-b]quinazolinone (IQ) derivatives, IQ-7 and IQ-12, and their effect on the Nrf2/ARE signaling pathway.
Methods: We initially measured the cytotoxicity of IQ-7 and IQ-12 in Hep3B (human hepatoma cell) and HL-7702 (normal human liver cell) cell lines, then further detected their effects on Nrf2/ARE signaling pathway and apoptosis. Results: IQ-7 and IQ-12 downregulated the expression levels of Nrf2 and its downstream target genes, such as NQO1, HO-1 and Gclc. In Hep3B cells treated with IQ-7 or IQ-12, the mitochondrial membrane potential decreased dramatically while the expression level of the pro-apoptotic protein VDAC1 and anti-apoptotic protein Bcl-2 significantly increased and decreased, respectively. In addition, IQ-7 (but not IQ-12) also induced the activity of Caspase-3. Interestingly, IQ-7 appeared to selectively inhibit Hep3B cells while having rare adverse effect on HL-7702 cells. Conclusion: The two compounds were shown to induce apoptosis and inhibit the Nrf2/ARE signaling pathway in Hep3B cells, and IQ-7 was suggested a degree of specificity against cancer cells. The design of these compounds may therefore represent a new strategy for designing quinazoline derivatives that could selectively target carcinoma cells.Export Options
About this article
Cite this article as:
Y. Zhang, R. Qiao, D. He, Z. Zhao, S. Yang, H. Zou, X. Zhang, M. Wu, J. Chen, P. Chen , Indazolo[3,2-b]quinazolinones Attack Hepatocellular Carcinoma Hep3B Cells by Inducing Mitochondrial-Dependent Apoptosis and Inhibition of Nrf2/ARE Signaling Pathway, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161128114444
DOI https://dx.doi.org/10.2174/1566524016666161128114444 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
Call for Papers in Thematic Issues
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders
Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Contribution of Dietary Factors to Peroxisome Proliferator-Activated Receptor-Mediated Inflammatory Signaling in Arthritic Diseases
Current Rheumatology Reviews Therapeutic Potential of Inhibiting Brutons Tyrosine Kinase, (BTK)
Current Pharmaceutical Design Chitinases: Biomarkers for Human Diseases
Protein & Peptide Letters Multi-target Drug Discovery via PTML Modeling: Applications to the Design of Virtual Dual Inhibitors of CDK4 and HER2
Current Topics in Medicinal Chemistry A New Strategy for Obesity Treatment: Revealing the Frontiers of Anti-obesity Medications
Current Molecular Medicine Isoform-Selective PI3K Inhibitors for Various Diseases
Current Topics in Medicinal Chemistry Evaluation of Tricine and EDDA as Co-ligands for <sup>99m</sup>Tc-Labeled HYNIC-MSH Analogs for Melanoma Imaging
Anti-Cancer Agents in Medicinal Chemistry Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design A Review on Structures and Functions of Bcl-2 Family Proteins from Homo sapiens
Protein & Peptide Letters Marine-derived Natural Products as Anticancer Agents
Medicinal Chemistry Organophosphorus Chemistry: Therapeutic Intervention in Mechanisms of Viral and Cellular Replication
Current Organic Chemistry Structure-based Virtual Screening Approaches in Kinase-directed Drug Discovery
Current Topics in Medicinal Chemistry Computational Peptidology: A New and Promising Approach to Therapeutic Peptide Design
Current Medicinal Chemistry Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Equilibrative Nucleoside Transporters in Fetal Endothelial Dysfunction in Diabetes Mellitus and Hyperglycaemia
Current Vascular Pharmacology Dehydrocholesterol Reductase 24 (DHCR24): Medicinal Chemistry, Pharmacology and Novel Therapeutic Options
Current Medicinal Chemistry Effects of Alcohol in the Lung
Current Respiratory Medicine Reviews Nanotechnology a Boon for Colorectal Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Newer Avenues for the Treatment of Leptomeningeal Carcinomatosis
Central Nervous System Agents in Medicinal Chemistry The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets
Current Medicinal Chemistry